Come up with a name for your new list and we'll add to it:
Genzyme raised a round of funding on January 01, 1998. Investors include
SV Health Investors.
Genzyme, a biotechnology company, engages in the discovery and development of products and services primarily in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases, and en…